Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates(DIs) and Active Pharmaceutical Ingredients (APIs) In India.
Related Links
Related Links
-
National Pharmaceuticals Pricing Policy 2012 by Department of Pharmaceuticals
Information about National Pharmaceuticals Pricing Policy 2012 (NPPP 2012) by Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers is given. Users can get details related to preamble of policy, its objectives, principles, essential issues for implementation of policy, policy implementation, etc.
-
Website of Department of Pharmaceuticals
The Department of Pharmaceuticals was created on the 1st of July in the year 2008 in the Ministry of Chemicals and Fertilizers so as to provide greater focus for the growth of the high potential Pharmaceuticals industry. Users can get information of the department, functions, business, agencies, schemes, essential medicines, environment cell and industry activities. Details of the Environment cell are also given for the users.
-
Contact Details, Department of Pharmaceuticals
Get contact numbers of Department of Pharmaceuticals. Name, designation, telephone number and other contact details of the officials are available. Users can also find the address and email ids.
-
Cluster development Scheme, Department of Pharmaceuticals
Department of Pharmaceuticals (DoP) has announced the Scheme for Cluster Development Programme for Pharma Sector in July 2014 to enhance quality, productivity and innovative capabilities of the SME pharma sector in the country.
-
Pharmaceutical Promotion Development Scheme, Department of Pharmaceuticals
The objective of Pharmaceutical Promotion Development Scheme (PPDS) is promotion, development and export promotion in Pharmaceutical sector by extending financial support for conduct of seminars, conferences, and exhibition, mounting delegations to and from India for promotion of exports as well as investments, conducting studies / consultancies, for facilitating growth, exports as well as critical issues affecting Pharma sector.
-
TB and Kala azar Scheme, Department of Pharmaceuticals
Scheme on Target specific New Drug Discovery for Anti Tubercular Agents aims at discovering high affinity ligands that can be developed into efficacious and less toxic drugs against TB. Among other things, this proposal use technique of post genomic era in identifying the role of specific gene in causing and counteracting diseases. Phase I of the project has duration of 3 years and Phase II of 2 years.
-
Janaushadhi Scheme, Department of Pharmaceuticals
In 2008 Department of Pharmaceuticals started the Jan Aushadhi Scheme which seeks to provide to the common man good quality generic medicines at very reasonable and affordable prices through Jan Aushadhi Stores (JAS) all over the country.
-
Implementation of Scheme for Schedule M Compliance for SSI Pharma Units, Department of Pharmaceuticals
As per the second supplement of the Revised Guidelines issued by MSME on the Credit Linked Capital Subsidy Scheme (CLCSS) for Technology Up-gradation of Micro, Small and Medium Enterprises by the Ministry of MSME on 13th July, 2009 the pharma SSI units will now be able to avail the benefits of CLCS Scheme for financial assistance for an expanded list of products.
-
Detailed Demands for Grants, Department of Pharmaceuticals
Find Demands for Grants for Department of Pharmaceuticals under Ministry of Chemicals & Fertilizers. Details such as revenue, capital, total grant amount of money, etc are available. Users can view and download the files.
-
Scheme for Strengthening of Pharmaceuticals Industry (SPI)
This scheme addresses the demand and requirement for support to already existing pharma clusters and MSMEs to improve productivity, quality and sustainability.
-
Production Linked Incentive (PLI) scheme for Pharmaceuticals
The objective of the scheme is to enhance India's manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high value goods in the pharmaceutical sector.
-
Scheme for Promotion of Medical Device Parks
Easy access to standard testing and infrastructure facilities through creation of world class common infrastructure facilities for increased competitiveness will result into significant reduction of the cost of production of medical devices leading to better availability and affordability of medical devices in the domestic market.